Review the following patient clinical profiles and match each with the single most appropriate next step in preventive care or screening based on current evidence-based guidelines.
- A healthy 42-year-old woman establishes care at the clinic; her family history is notable for a father diagnosed with colorectal cancer at age 49.Schedule a screening colonoscopy
- A 66-year-old man with a 30-pack-year history of tobacco use who permanently stopped smoking 16 years ago; his last colonoscopy was normal 11 months ago.Perform one-time abdominal ultrasonography
- A 28-year-old woman who is currently receiving daily mycophenolate mofetil therapy for the management of systemic lupus erythematosus.Administer the recombinant zoster vaccine
- A 52-year-old woman who previously underwent surgical removal of her uterus and cervix for benign leiomyomas; her routine screenings are otherwise current.Discontinue routine cervical cancer screening
- A 54-year-old woman without chronic medical conditions who currently consumes one pack of cigarettes daily and has accumulated a 25-pack-year exposure.Order low-dose computed tomography of the chest
Cevap
Match the 42-year-old woman to the colonoscopy, the 66-year-old man to the abdominal ultrasound, the 28-year-old woman to the recombinant zoster vaccine, the 52-year-old woman to discontinuing cervical screening, and the 54-year-old woman to low-dose computed tomography.
Each patient presentation corresponds to a unique guideline-concordant intervention. The 42-year-old requires early colonoscopy due to a first-degree relative with early-onset CRC. The 66-year-old man requires an abdominal ultrasound for AAA screening as a former smoker, but avoids LDCT because his quit date exceeds 15 years. The 28-year-old requires the zoster vaccine due to systemic immunosuppression. The 52-year-old discontinues Pap smears following a benign total hysterectomy. The 54-year-old current smoker meets all criteria for annual LDCT.
Adım Adım Çözüm
Anahtar Kavram
Application of age- and risk-modified preventive care guidelines, including familial cancer syndromes, immunizations in immunocompromised states, and screening cessation criteria.